Article
Unlocking New Treatment Horizons for Celiac Disease: PRKCD Revealed as a Promising Target through Mendelian Randomization
Endocrine, metabolic & immune disorders drug targets - 1 Jan 2026
Zhou Jie, Xu Yixin, Wang Haitao, Wang Kun, Chen Chao
Abstract excerpt
INTRODUCTION: Celiac Disease (CeD) is a serious, lifelong autoimmune condition. There remains a significant unmet medical need for effective pharmacological treatments for CeD. METHODS: We utilized summary statistics for 2,888 druggable genes from the eQTLGen Consortium and the FinnGen Consortium for CeD. In our Mendelian Randomization (MR) analysis, we identified genes associated with CeD that had a false...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
